Drug profile · INN
motixafortide acetate
APHEXDA
motixafortide acetate (APHEXDA) is an FDA-listed pharmaceutical active ingredient. Route of administration: subcutaneous. Current US regulatory status: approved.
Drug details — motixafortide acetate
- US status
- approved
- Class
- —
- Route
- SUBCUTANEOUS
- Patents
- 0
- Programs
- 1
- Data quality
- 0.84
Quick answer
motixafortide acetate (APHEXDA) is an FDA-listed pharmaceutical active ingredient. Route of administration: subcutaneous. Current US regulatory status: approved.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Frequently asked questions
What is motixafortide acetate?
motixafortide acetate (APHEXDA) is an FDA-listed pharmaceutical active ingredient. Route of administration: subcutaneous. Current US regulatory status: approved.
What is the brand name for motixafortide acetate?
APHEXDA is a marketed brand name for motixafortide acetate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of motixafortide acetate?
motixafortide acetate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.